HCP Inc., an Irvine, Calif.-based REIT, has signed a definitive agreement to acquire life science property 35 CambridgePark Drive in Cambridge, Mass., for $332.5 million.
“With the acquisition of 35 CambridgePark Drive, we’re pleased to report that in less than two years we have expanded our presence in the Boston life science market to more than 1.3 million square feet and at a very compelling blended yield,” said Scott Brinker, executive vice president and CIO of HCP. “Class A life science real estate continues to experience unprecedented demand and the cluster strategy we have employed, combined with our mix of stabilized and development properties, will allow our tenants to grow within our portfolio.”
The 224,000-square-foot LEED Gold certified lab building is being purchased from a partnership of The Davis Cos. and Invesco Real Estate, which developed the
